Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Athersys Inc.
()
Athersys Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Study of MultiStem® Treatment for Ischemic Stroke (9/28/2016)
view
Cesca Therapeutics Inc.
(KOOL:NASDAQ)
Cesca Therapeutics to Present & Exhibit at the ISCT North America 2016 Regional Meeting (9/27/2016)
view
Viveve Medical Inc.
(VIVE:NASDAQ)
Viveve Submits Investigational Device Exemption (IDE) for VIVEVE II (9/27/2016)
view
RepliCel Life Sciences Inc.
(RP:TSX.V; REPCF:OTCQB)
RepliCel Announces Debt Settlement (9/27/2016)
view
RepliCel Life Sciences Inc.
(RP:TSX.V; REPCF:OTCQB)
RepliCel Provides Update on Shiseido License and Co-Development for RCH-01 (9/26/2016)
view
Actinium Pharmaceuticals Inc.
(ATNM:NYSE.MKT)
Actinium Announces Initiation of Phase 2 Clinical Trial of Actimab-A in Patients Newly Diagnosed with Acute Myeloid Leukemia Over Age 60 (9/27/2016)
view
DURECT Corp.
(DRRX:NASDAQ)
DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER (oxycodone) Extended-Release Capsules CII (9/26/2016)
view
Actinium Pharmaceuticals Inc.
(ATNM:NYSE.MKT)
Actinium Pharmaceuticals to Sponsor and Participate in Be The Match® Walk+Run to Raise Awareness for Bone Marrow Transplant (9/26/2016)
view